Sterling slumps on ‘no-deal Brexit’ worries; stocks dip
The British pound touched its lowest level in over two years against the dollar after Prime Minister Boris Johnson said a hard divorce from the...
Beyond Meat beats revenue estimates, raises forecast as demand sizzles
Beyond Meat Inc beat second-quarter revenue estimates and raised its full-year forecast on Monday, as the company’s plant-based burgers and sausages saw booming demand with...
Wall St. takes a pause in wait for Fed news, trade progress
U.S. stocks stepped back from peak levels on Monday as investors took a breather as they anticipated a U.S. Federal Reserve interest rate cut this...
Beyond Meat beats quarterly revenue estimates, raises forecast
Beyond Meat Inc beat second-quarter revenue estimates and raised its full-year forecast on Monday, as the company’s plant-based burgers and sausages saw booming demand with...
Germany’s Bayer dealt new legal blow as more Brazil farmers challenge soy patent
Germany’s Bayer AG , which completed the takeover of U.S.-based Monsanto last year, has been dealt a legal blow in Brazil as more farmers joined...
Citi combines its stock trading and prime brokerage business
Citigroup is combining its stock trading business with its prime brokerage unit, which caters to hedge funds, private equity firms and other investors....
Exclusive: India’s SBI tightens lending terms for auto dealers – source, internal memo
State Bank of India (SBI) has tightened lending terms dramatically for auto dealerships, according to a source and an internal memo seen by Reuters, seeking...
Columbia Threadneedle names senior research director
Columbia Threadneedle Investments, the asset management arm of Ameriprise Financial Inc, on Monday named Stuart Jarvis senior research director, to strengthen its global investments solutions...
Sterling tumbles on hard Brexit worries; stocks slip
The British pound on Monday touched its lowest against the dollar since early 2017 after Prime Minister Boris Johnson’s government said it now assumed there...
Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman
Pfizer Inc is in talks to merge its contract manufacturer that produces Mylan’s EpiPen emergency allergy treatment into the new generics business it is creating...
